Change is here!
See change™ in protein characterization.
Our CTO, Eugene Ma, is on hand to answer any questions on your application, sample or our technology. Submit your question and he will get back to you directly.
The Next Generation in Protein Characterization
The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:
Aggregation | Quantitation | Stability | Structure | Similarity
See change in your protein, in your workflow, and in your efficiency.
Visit the product page to learn more.
Watch our latest webinar replay
Latest News
RedShiftBio Expands Team to Support Launch of FlagShip AQS3™pro System for Protein Characterization.
Instrument Business Outlook interviews RedShiftBio CCO Jeff Zonderman on the launch of the AQS3pro.
Spectroscopy Europe highlights the launch of the AQS3pro.
RedShiftBio Launches AQS3pro Protein Characterization System.
Biotherapeutics and Vaccines Development
Gordon Research Conference, Jan 6-11, 2019, Galveston, TX
Peptalk 2019, Jan 14-18, 2019, San Diego, CA
WCBP, Jan 29 - 31, 2019, Washington, DC
RedShiftBio™
RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.
Learn More
MMS For Protein Therapeutic Drug Analysis
Enhanced Protein Structural Characterization using MMS
Contact Us
RedShift BioAnalytics Inc.
131 Middlesex Turnpike
Burlington, MA 01803
T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com
RedShift™, RedShiftBio™, See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.